Hydroxyurea-based treatment for sickle cell anemia previously available for pediatric patients …

ROSEMONT, PA, Feb. 16, 2022 (GLOBE NEWSWIRE) — Medunik USA is pleased to announce that Siklos® (hydroxyurea), previously indicated to reduce the frequency of painful crises and to reduce the